Skip to content

QIST Collaborative - Arthroplasty Research Cohort (ARC) Study

QIST Collaborative - Arthroplasty Research Cohort (ARC) Study - a Collaborative, Longitudinal Observational Cohort Study of Patients Undergoing Primary Hip and Knee Replacements in the United Kingdom

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05824845
Enrollment
5000
Registered
2023-04-24
Start date
2023-07-13
Completion date
2031-05-31
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Arthritis, Knee Arthritis

Keywords

Hip Replacement, Knee Replacement

Brief summary

The ARC Study is a national observational cohort study to investigate patient reported and clinical outcomes after hip and knee replacements. The study has the following objectives: 1. To evaluate outcomes following hip and knee replacements. 2. To determine risk factors for adverse outcomes in primary hip and knee replacements. 3. To identify targets for future research and intervention in patients undergoing primary hip and knee replacements 4. To provide a resource from which to identify potential participants for future clinical trials, and to use data collected in the ARC Study as comparison or control data for trial participants who have been randomised to receive one or more interventions. Participants are recruited and consented online. Patients are invited to participate by collaborating surgical teams nationally in outpatient clinics at the time of being added to a waiting list, in addition to an advertising campaign to recruit patients. They are directed to an online portal where they will be able to review further information. Consent and data collection is completed electronically through patients entering data online. Baseline demographics and characteristics are recorded, including details of socio-demographics, lifestyle, health status and patient reported outcome measures (PROMs). Patients then undergo hip/knee replacement and postoperative rehabilitation according to the standard care and protocols of the hospital and the preferences of their treating surgeon. Follow-up data, including PROMs, is collected via online questionnaires up to two years following surgery. The study will ultimately also enable multiple trials to be embedded within the cohort study, using a 'Trials within Cohorts' (TwiCs) methodology.

Interventions

Hip/Knee Replacement

Sponsors

University of York
CollaboratorOTHER
Northumbria Healthcare NHS Foundation Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Participants must meet all of the inclusion criteria: 1. UK Resident 2. Able to read and understand documentation and questionnaires in English language 3. Undergoing elective primary hip or knee arthroplasty (THR, TKR or UKR) 4. Age 18 years or over 5. Provides the necessary consents relating to data collection and use of study data, data linkage, future research and invitation to involvement in future trials

Exclusion criteria

Provided a participant meets all of the inclusion criteria, there are no

Design outcomes

Primary

MeasureTime frame
EQ-5D-5L health-related quality of life score2 years

Secondary

MeasureTime frameDescription
Oxford Hip Score2 years
Oxford Knee Score2 years
Musculoskeletal Health Questionnaire2 yearsMSK-HQ
Hospital for Special Surgery Hip/Knee Replacement Expectations Surveys2 yearsPerception of success/fulfilment of expectations
Patient Health Questionnaire-42 yearsPHQ-4
11-point Numerical Pain Rating Scale2 yearsPain
Pain Catastrophising Scale2 years
Length of stay2 yearsSelf-reported by study specific electronic questionnaire
PROMIS-102 yearsPatient-Reported Outcomes Measurement Information System Global Health
Return to work2 yearsWork status self-reported by electronic questionnaire using National Statistics Socio-economic Classification
Readmission within 30 days30 days
Surgical Site Infection2 years
Periprosthetic Fracture2 years
Dislocation2 years
Revision/Re-operation2 years
Mortality2 years
Activity2 yearsLevels of exercise and activity self-reported by study specific electronic questionnaire

Countries

United Kingdom

Contacts

Primary ContactWilliam Fishley
arcstudy@northumbria-healthcare.nhs.uk01912934087

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026